文献速递垂体与肾上腺疾病

circOMA1通过吸附miR-145-5p靶向TPT1促进无功能垂体腺瘤进展

circOMA1-Mediated miR-145-5p Suppresses Tumor Growth of Nonfunctioning Pituitary Adenomas by Targeting TPT1.
PubMed 文献 · J Clin Endocrinol Metab · 2019-01-01

本研究探讨circRNA-miRNA-mRNA轴在无功能垂体腺瘤(NFPA)发生中的作用机制。体外和体内实验显示miR-145-5p在NFPA样本中显著降低且与侵袭性负相关,其过表达抑制细胞增殖和侵袭并促进凋亡。circOMA1作为miR-145-5p的分子海绵,通过调控TPT1及其下游Mcl-1、Bcl-xL和Bax促进NFPA进展。

要点

  • miR-145-5p在NFPA中显著降低且与侵袭性负相关
  • miR-145-5p过表达抑制NFPA细胞增殖侵袭并促进凋亡
  • circOMA1通过吸附miR-145-5p调控TPT1信号通路促进NFPA进展

核心结论

  • circOMA1通过充当肿瘤抑制因子miR-145-5p的分子海绵调控TPT1信号通路促进NFPA进展,揭示潜在治疗靶点。

研究设计与样本

  • 在体外和体内研究miR-145-5p在NFPA中的功能,探索机制并鉴定其潜在靶点,最终功能识别并确认相关circRNA。

主要发现

  • miR-145-5p在NFPA样本中显著降低且与NFPA侵袭性负相关。
  • miR-145-5p过表达抑制NFPA细胞增殖和侵袭并促进凋亡。
  • TPT1是miR-145-5p的靶点并介导其效应,miR-145-5p下调TPT1及其下游Mcl-1和Bcl-xL并上调Bax。
  • circOMA1(hsa_circRNA_0002316)吸附miR-145-5p,circOMA1过表达可消除miR-145-5p对NFPA细胞的抑制作用。
  • circOMA1沉默通过下调TPT1表现出与miR-145-5p过表达相似的抑制效果。

临床怎么用

  • circOMA1/miR-145-5p/TPT1轴可能作为NFPA肿瘤发生的治疗靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Nonfunctioning pituitary adenomas (NFPAs) are the major cause of hypopituitarism and infertility. However, the pathogenesis of NFPAs remains largely unknown. Previous studies have demonstrated the crucial role of miRNAs in the progression of pituitary adenomas. Increasing evidence has indicated that circular RNAs (circRNAs) might mediate miRNA transcriptional activity, providing new insights to study the pathogenesis of NFPAs. OBJECTIVES: To explore the regulation and activity of the circRNA-miRNA-mRNA axis in the tumorigenesis of NFPAs. DESIGN: The function of miR-145-5p in NFPAs was investigated invitro and invivo. The mechanical details were explored and potential targets of miR-145-5p were identified. Finally, miR-145-5p-associated circRNAs were functionally recognized and confirmed. RESULTS: miR-145-5p was markedly decreased in NFPA samples and correlated negatively with NFPA invasiveness. Overexpression of miR-145-5p suppressed NFPA cell proliferation and invasiveness and promoted apoptosis. Further results confirmed that translationally controlled tumor protein (TPT1) is a target of miR-145-5p and mediated the effect of miR-145-5p. TPT1 and its downstream factors Mcl-1 and Bcl-xL were downregulated, and Bax was upregulated by miR-145-5p. Moreover, circOMA1 (hsa_circRNA_0002316) was demonstrated to sponge miR-145-5p, whose suppression on NFPA cells was abrogated by circOMA1 overexpression. circOMA1 silencing exhibited a similar inhibitory effect with miR-145-5p overexpression by downregulating TPT1. We found that circOMA1 could further upregulate Mcl-1 and Bcl-xL and downregulate Bax. CONCLUSIONS: circOMA1 promotes NFPA progression by acting as the sponge of tumor suppressor miR-145-5p to regulate the TPT1 signaling pathway, revealing a therapeutic target in preventing the tumorigenesis of NFPAs.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Du Q, Hu B, Feng Y, et al. circOMA1-Mediated miR-145-5p Suppresses Tumor Growth of Nonfunctioning Pituitary Adenomas by Targeting TPT1. J Clin Endocrinol Metab. 2019. PMID: 30721952. doi:10.1210/jc.2018-01851

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。